Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 434

1.

Decline in cognitive and functional skills increases mortality risk in nondemented elderly.

Schupf N, Tang MX, Albert SM, Costa R, Andrews H, Lee JH, Mayeux R.

Neurology. 2005 Oct 25;65(8):1218-26.

PMID:
16247048
2.

Preservation of cognitive and functional ability as markers of longevity.

Schupf N, Costa R, Tang MX, Andrews H, Tycko B, Lee JH, Mayeux R.

Neurobiol Aging. 2004 Oct;25(9):1231-40.

PMID:
15312969
3.

Relationship between plasma lipids and all-cause mortality in nondemented elderly.

Schupf N, Costa R, Luchsinger J, Tang MX, Lee JH, Mayeux R.

J Am Geriatr Soc. 2005 Feb;53(2):219-26.

PMID:
15673344
4.

Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss.

Bozoki A, Giordani B, Heidebrink JL, Berent S, Foster NL.

Arch Neurol. 2001 Mar;58(3):411-6.

PMID:
11255444
5.

The hierarchy of functional loss associated with cognitive decline in older persons.

Njegovan V, Hing MM, Mitchell SL, Molnar FJ.

J Gerontol A Biol Sci Med Sci. 2001 Oct;56(10):M638-43.

PMID:
11584037
6.

Cognitive decline in high-functioning older persons is associated with an increased risk of hospitalization.

Chodosh J, Seeman TE, Keeler E, Sewall A, Hirsch SH, Guralnik JM, Reuben DB.

J Am Geriatr Soc. 2004 Sep;52(9):1456-62.

PMID:
15341546
7.

Black-white disparities in functional decline in older persons: the role of cognitive function.

Moody-Ayers SY, Mehta KM, Lindquist K, Sands L, Covinsky KE.

J Gerontol A Biol Sci Med Sci. 2005 Jul;60(7):933-9.

PMID:
16079221
8.

Verbal and visuospatial deficits in dementia with Lewy bodies.

Johnson DK, Morris JC, Galvin JE.

Neurology. 2005 Oct 25;65(8):1232-8.

PMID:
16247050
9.

Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community.

Manly JJ, Bell-McGinty S, Tang MX, Schupf N, Stern Y, Mayeux R.

Arch Neurol. 2005 Nov;62(11):1739-46.

PMID:
16286549
10.

Increase in epinephrine excretion is associated with cognitive decline in elderly men: MacArthur studies of successful aging.

Karlamangla AS, Singer BH, Greendale GA, Seeman TE.

Psychoneuroendocrinology. 2005 Jun;30(5):453-60.

PMID:
15721057
11.

Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.

Rozzini L, Chilovi BV, Bertoletti E, Conti M, Del Rio I, Trabucchi M, Padovani A.

Int J Geriatr Psychiatry. 2006 Jun;21(6):550-5.

PMID:
16642542
12.

MRI measures and progression of cognitive decline in nondemented elderly attending a memory clinic.

van der Flier WM, van der Vlies AE, Weverling-Rijnsburger AW, de Boer NL, Admiraal-Behloul F, Bollen EL, Westendorp RG, van Buchem MA, Middelkoop HA.

Int J Geriatr Psychiatry. 2005 Nov;20(11):1060-6.

PMID:
16250078
13.

Terminal-decline effects for select cognitive tasks after controlling for preclinical dementia.

Laukka EJ, MacDonald SW, Bäckman L.

Am J Geriatr Psychiatry. 2008 May;16(5):355-65. doi: 10.1097/JGP.0b013e318160f312.

PMID:
18448848
14.

Cardiovascular diseases and decline in cognitive function in an elderly community population: the Edinburgh Artery Study.

Rafnsson SB, Deary IJ, Smith FB, Whiteman MC, Fowkes FG.

Psychosom Med. 2007 Jun;69(5):425-34. Epub 2007 Jun 7.

PMID:
17556639
15.

A systematic review of cognitive decline in the general elderly population.

Park HL, O'Connell JE, Thomson RG.

Int J Geriatr Psychiatry. 2003 Dec;18(12):1121-34. Review.

PMID:
14677145
16.

The relationship between age, gender and cognitive performance in the very old: the effect of selective survival.

Perls TT, Morris JN, Ooi WL, Lipsitz LA.

J Am Geriatr Soc. 1993 Nov;41(11):1193-201.

PMID:
8227893
17.

Establishing the limits and characteristics of normal age-related cognitive decline.

Ritchie K, Touchon J, Ledésert B, Leibovici D, Gorce AM.

Rev Epidemiol Sante Publique. 1997 Oct;45(5):373-81.

PMID:
9407625
18.

A prospective study of cognitive function in the elderly.

Korten AE, Henderson AS, Christensen H, Jorm AF, Rodgers B, Jacomb P, Mackinnon AJ.

Psychol Med. 1997 Jul;27(4):919-30.

PMID:
9234469
19.

The neuroprotective effects of caffeine: a prospective population study (the Three City Study).

Ritchie K, Carrière I, de Mendonca A, Portet F, Dartigues JF, Rouaud O, Barberger-Gateau P, Ancelin ML.

Neurology. 2007 Aug 7;69(6):536-45.

PMID:
17679672
20.

Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.

Arch Neurol. 2007 Sep;64(9):1306-11.

PMID:
17846270

Supplemental Content

Support Center